GDF15 and metabolic dysfunction-associated steatotic liver disease: In particular, GDF15 represents an independent determinant of fibrosis severity in NAFLD: (1) patients with more severe chronic liver diseases have proportionately higher GDF15 values and (2) plasma GDF15 concentrations are associated with liver fibrosis regardless of diabetes status [12, 13].